Parkinsons Disease Treatment Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

Parkinson's disease is a degenerative nervous system disorder that affects people's ability to move. Parkinson's disease symptoms begin slowly, with tremors in one hand that are barely noticeable. Stiffness, rigid muscles, impaired posture and balance, loss of automatic movement, and slowness of movement are common symptoms of the disease. The Parkinson's disease cannot be completely cured, drugs can help to relieve its symptoms. Parkinson's disease treatment consist of use of several category of drugs to manage symptoms and further complications.

MARKET SCOPE

The "Global Parkinsons Disease Treatment Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the parkinsons disease treatment market with detailed market segmentation by drug class and distribution channel. The report provides key statistics on the market status of the leading parkinsons disease treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•   Based on drug class the market is segmented as, carbidopa/levodopa, dopamine receptor agonists, Mao inhibitors, COMT inhibitors, anticholinergic and other drugs.
•   Based on distribution channel the market is segmented as, hospital pharmacies, retail pharmacies, and online pharmacies.

MARKET DYNAMICS
Drivers:

•   Increasing prevalence of neurodegenerative disorders like Parkinson's disease and growing geriatric population across the globe.
•   Ongoing research and development activities for development of novel treatment approches.
•   Various government fundings for research activities and presence of strong pipeline of therapeutic agents for management of disease.

Restraints:

•   However, availability of alternative treatment options are expected to restrain market growth during the forecast period.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The parkinsons disease treatment market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the parkinsons disease treatment market in these regions.

IMPACT OF COVID-19 ON PARKINSONS DISEASE TREATMENT MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. Also, due to COVID-19 outbreak the parkinsons disease market is affected negatively as the clinical trials for new products delayed due to lockdowns, people cannot able to make their regular appointments as COVID-19 risk is more for elder patients. In addition, telemedicine practices are grown during the pandemic for assistance and guidance of patients with neurodegenerative disorders. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

Parkinsons Disease Treatment Market Report Analysis

Parkinsons Disease Treatment Market

• 
  CAGR (2023 - 2031)

  XX%
• Market Size 2023
  US$ XX Million
• Market Size 2031
  US$ XX Million

Report Coverage

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis

• Industry landscape and competition analysis & recent developments
• Detailed company profiles

• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

• Teva Pharmaceutical Industries Ltd
• AbbVie Inc
• Boehringer Ingelheim International GmbH.
• H. Lundbeck A/S
• Amneal Pharmaceuticals LLC
• Bausch Health Companies Inc
• GlaxoSmithKline plc
• Acadia Pharmaceuticals Inc
• Kyowa Kirin Co., Ltd

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

By Drug Class

• Levodopa or carbidopa
• Dopamine Receptor Agonists
• MAO-Inhibitors
• COMT-inhibitors Anticholinergics
• Other Drugs

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

MARKET PLAYERS

The report covers key developments in the parkinsons disease treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from parkinsons disease treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for parkinsons disease treatment in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the parkinsons disease treatment market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

•   Teva Pharmaceutical Industries Ltd
•   AbbVie Inc
•   Boehringer Ingelheim International GmbH.
•   H. Lundbeck A/S
•   Amneal Pharmaceuticals LLC
•   Bausch Health Companies Inc
•   GlaxoSmithKline plc
•   Acadia Pharmaceuticals Inc
•   Kyowa Kirin Co., Ltd
•   UCB S.A

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Parkinsons Disease Treatment Market Report Scope